6185-28-0 Usage
Uses
Used in Food and Beverage Industry:
Sodium 2,6-difluorobenzoate is used as a food preservative to extend the shelf life of various food products by inhibiting the growth of bacteria, yeasts, and molds. Its ability to regulate pH also helps maintain the stability and quality of food and beverages.
Used in Flavoring Industry:
As a flavoring agent, Sodium 2,6-difluorobenzoate enhances the taste and aroma of food and beverage products, contributing to their overall sensory appeal.
Used in Pharmaceutical Synthesis:
Sodium 2,6-difluorobenzoate is utilized in the synthesis of pharmaceuticals, where its unique chemical properties contribute to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Synthesis:
In the agrochemical industry, Sodium 2,6-difluorobenzoate is employed in the synthesis of various agrochemicals, such as pesticides and herbicides, to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 6185-28-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,1,8 and 5 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6185-28:
(6*6)+(5*1)+(4*8)+(3*5)+(2*2)+(1*8)=100
100 % 10 = 0
So 6185-28-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H4F2O2.Na/c8-4-2-1-3-5(9)6(4)7(10)11;/h1-3H,(H,10,11);/q;+1/p-1
6185-28-0Relevant academic research and scientific papers
OXAZOLE TYROSINE KINASE INHIBITORS
-
Page/Page column 89, (2009/01/20)
The invention provides a compound which is an amide of the formula (1), or a salt, solvate, N-oxide or tautomer thereof; wherein: a is 0 or 1; b is 0 or 1 : provided that the sum of a and b is 0 or 1; T is O or NH Ar1 is a monocyclic or bicyclic 5- to 10-membered aryl or heteroaryl group containing up to 4 heteroatoms selected from O, N and S, and being optionally substituted by one or more substituents R1; Ar2 Js a monocyclic or bicyclic 5- to 10-membered aryl or heteroaryl group containing up to 4 heteroatoms selected from O, N and S and being optionally substituted by one or more substituents R2; and R1 and R2are as defined in the claims. The compounds are inhibitors of kinases and in particular FLT3, FLT4 and Aurora kinases.
